nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP1—cardiovascular system—nicotine dependence	0.0902	0.104	CbGeAlD
Minocycline—CYCS—cardiovascular system—nicotine dependence	0.0869	0.1	CbGeAlD
Minocycline—CASP3—cardiovascular system—nicotine dependence	0.0744	0.0859	CbGeAlD
Minocycline—CASP1—midbrain—nicotine dependence	0.0705	0.0813	CbGeAlD
Minocycline—CYCS—midbrain—nicotine dependence	0.0678	0.0783	CbGeAlD
Minocycline—IL1B—cardiovascular system—nicotine dependence	0.0594	0.0686	CbGeAlD
Minocycline—MMP9—cardiovascular system—nicotine dependence	0.0495	0.0572	CbGeAlD
Minocycline—IL1B—midbrain—nicotine dependence	0.0464	0.0536	CbGeAlD
Minocycline—CASP1—brain—nicotine dependence	0.0443	0.0511	CbGeAlD
Minocycline—CYCS—brain—nicotine dependence	0.0426	0.0492	CbGeAlD
Minocycline—ALOX5—cardiovascular system—nicotine dependence	0.0392	0.0452	CbGeAlD
Minocycline—CASP3—brain—nicotine dependence	0.0365	0.0421	CbGeAlD
Minocycline—IL1B—brain—nicotine dependence	0.0292	0.0337	CbGeAlD
Minocycline—VEGFA—brain—nicotine dependence	0.0287	0.0331	CbGeAlD
Minocycline—MMP9—brain—nicotine dependence	0.0243	0.0281	CbGeAlD
Minocycline—SLC22A7—brain—nicotine dependence	0.0225	0.026	CbGeAlD
Minocycline—SLC22A6—brain—nicotine dependence	0.0217	0.0251	CbGeAlD
Minocycline—ALOX5—brain—nicotine dependence	0.0192	0.0222	CbGeAlD
Minocycline—CASP3—Cell death signalling via NRAGE, NRIF and NADE—FGD1—nicotine dependence	0.0167	0.125	CbGpPWpGaD
Minocycline—CASP3—p75 NTR receptor-mediated signalling—FGD1—nicotine dependence	0.0132	0.0984	CbGpPWpGaD
Minocycline—SLC22A8—brain—nicotine dependence	0.013	0.015	CbGeAlD
Minocycline—CYCS—Orphan transporters—GABRA4—nicotine dependence	0.0111	0.0828	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00619	0.0463	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—OPRM1—nicotine dependence	0.00594	0.0444	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0056	0.0419	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGD1—nicotine dependence	0.00484	0.0362	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00413	0.0309	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00399	0.0298	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00382	0.0286	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—WASF2—nicotine dependence	0.00376	0.0282	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00375	0.0281	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00374	0.028	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00373	0.0279	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—WASF1—nicotine dependence	0.00361	0.027	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00339	0.0254	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0027	0.0202	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00249	0.0186	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—WASF2—nicotine dependence	0.00249	0.0186	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—WASF1—nicotine dependence	0.00239	0.0178	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00226	0.0169	CbGpPWpGaD
Minocycline—CASP1—Immune System—WASF2—nicotine dependence	0.00145	0.0108	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0014	0.0105	CbGpPWpGaD
Minocycline—CASP1—Immune System—WASF1—nicotine dependence	0.00139	0.0104	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TAS2R16—nicotine dependence	0.00132	0.00991	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00127	0.00951	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP2A7—nicotine dependence	0.00127	0.00947	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00107	0.008	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGD1—nicotine dependence	0.00104	0.00778	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TAS2R16—nicotine dependence	0.00092	0.00688	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKR1B10—nicotine dependence	0.000918	0.00687	CbGpPWpGaD
Minocycline—IL1B—Immune System—WASF2—nicotine dependence	0.000906	0.00678	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000892	0.00667	CbGpPWpGaD
Minocycline—IL1B—Immune System—WASF1—nicotine dependence	0.000868	0.0065	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAS2R16—nicotine dependence	0.000798	0.00597	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2A7—nicotine dependence	0.00078	0.00583	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGD1—nicotine dependence	0.000722	0.0054	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WASF2—nicotine dependence	0.000647	0.00484	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKR1B10—nicotine dependence	0.000638	0.00477	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGD1—nicotine dependence	0.000627	0.00469	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WASF1—nicotine dependence	0.00062	0.00464	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—OPRM1—nicotine dependence	0.000559	0.00418	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKR1B10—nicotine dependence	0.000553	0.00414	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WASF2—nicotine dependence	0.000449	0.00336	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WASF1—nicotine dependence	0.000431	0.00322	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD2—nicotine dependence	0.000404	0.00302	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WASF2—nicotine dependence	0.00039	0.00292	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—OPRM1—nicotine dependence	0.000388	0.0029	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WASF1—nicotine dependence	0.000374	0.0028	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—OPRM1—nicotine dependence	0.000337	0.00252	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD2—nicotine dependence	0.00028	0.0021	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD2—nicotine dependence	0.000243	0.00182	CbGpPWpGaD
